AdAlta (ASX:1AD) 14-Day RSI: 56.22 (As of Jul. 12, 2026)


What is AdAlta 14-Day RSI?

AdAlta ASX:1AD 14-Day RSI is 56.22 as of Jul. 12, 2026. The stock has 2 warning signs investors should review. Among 1,422 Biotechnology companies, AdAlta ranks worse than 72.08% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2026-07-12), AdAlta's 14-Day RSI is 56.22.

The industry rank for AdAlta's 14-Day RSI or its related term are showing as below:

ASX:1AD's 14-Day RSI is ranked worse than
72.08% of 1422 companies
in the Biotechnology industry
Industry Median: 49.075 vs ASX:1AD: 56.22

AdAlta  (ASX:1AD) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.

AdAlta 14-Day RSI Related Terms

ASX:1AD vs VRTX, REGN, ALNY: 14-Day RSI Comparison

For the Biotechnology subindustry, AdAlta's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AdAlta 14-Day RSI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AdAlta's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where AdAlta's 14-Day RSI falls into.


AdAlta  (ASX:1AD) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100–[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 14-Day RSI →
What does a 14-Day RSI of 56.22 mean?
AdAlta (ASX:1AD) has a 14-Day RSI of 56.22 as of Jul. 12, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on AdAlta and its competitors. According to the industry distribution chart, AdAlta ranks #1025 out of 1422 companies in the Biotechnology industry, placing it in the top 72.1%.
Is AdAlta's 14-Day RSI too high?
AdAlta's current 14-Day RSI is 56.22. The Biotechnology industry median 14-Day RSI is 49.08. AdAlta's value of 56.22 is 14.6% above this industry median. Based on the distribution chart, AdAlta ranks #1025 out of 1422 companies in the Biotechnology industry, which is below the industry midpoint.
How does AdAlta's 14-Day RSI compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, AdAlta ranks #1025 out of 1422 companies for 14-Day RSI. This places AdAlta in the lower half of its industry. The industry median 14-Day RSI is 49.08. AdAlta's value of 56.22 is 14.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Biotechnology company?
The median 14-Day RSI among Biotechnology companies is 49.08, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AdAlta's current 14-Day RSI of 56.22 is 14.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on AdAlta and its competitors. For the Biotechnology industry, the median 14-Day RSI is 49.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AdAlta's current 14-Day RSI is 56.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AdAlta stock overvalued right now?
AdAlta (ASX:1AD) has a current 14-Day RSI of 56.22. The current 14-Day RSI is 56.22 and 14.6% above the Biotechnology industry median of 49.08. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For AdAlta (ASX:1AD), the current 14-Day RSI is 56.22 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AdAlta Business Description

Address 697 Burke Road, Suite 201, Camberwell, VIC, AUS, 3124
AdAlta Ltd is engaged in drug discovery and developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The principal business of AdAlta is the discovery and development of next-generation cells and protein based therapeutics. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases. Its pipeline includes Fibrosis and CAR-T cancer therapeutics.